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Abstract  
Objective: Because breath holding causes arterial pCO2 to increase, we used it to test the hypothesis that in panic disorder (PD) a 
biological suffocation monitor is pathologically sensitive.  
Method: Nineteen patients with PD, 17 with generalized anxiety disorder (GAD), and 22 normal controls took deep breaths on 
signal and held them until a release signal was given 30 seconds later. This was repeated 12 times separated by 60-second normal 
breathing periods.  
Results: PD patients reported having had in the past more symptoms of shortness of breath when anxious, and more frequent 
frightening suffocation experiences than the other groups. However, increases in self-rated anxiety between periods of normal 
breathing and periods of breath holding were similar in all three groups. Skin conductance, blood pressure, and T-wave amplitude 
reactions to breath holdings were also similar, but heart rate acceleration upon taking a deep breath was greater in GAD patients. 
Before and after individual breath holdings, end-tidal pCO2 was lower in PD patients than in normal controls; GAD patients were 
intermediate. Inspiratory flow rate did not differ between groups.  
Conclusions: Our physiological results provide no direct support for an overly sensitive suffocation alarm system in PD. Lower 
pCO2 may be due to anxiety causing hyperventilation in patients prone to panic.  
 
Key words: panic disorder, generalized anxiety disorder, respiration, breath holding, suffocation, autonomic nervous system.  
PD = panic disorder; GAD = generalized anxiety disorder; HR = heart rate; ANOVA = analysis of variance.  
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INTRODUCTIONtoctoc 
Klein [1,2] has hypothesized that in PD a biological suffocation monitor is pathologically sensitive and easily misfires leading to 
sudden respiratory distress, hyperventilation, panic, and an urge to flee. Recent evidence includes findings that the physiological 
symptom with the largest effect size for differentiating clinical and nonclinical panic is suffocation [3], and that a 0.5-mg/kg dose 
of the respiratory stimulant doxapram was able to trigger panic attacks in 75% of PD patients but in only 12.5% of normal controls 
[4]. In contrast, psychological theories of PD give a primary role to the fearful misinterpretation of bodily sensations, particularly 
those that are associated with anxiety [5-7]. Fear of physical sensations is a good predictor of fear responses to hyperventilation 
and CO2 challenge in anxiety disorder patients [8] and in nonclinical subjects [9,10]. The potential importance of psychological 
factors was demonstrated in the doxapram study cited above, in that a cognitive intervention was able to attenuate (although not to 
obliterate completely) the effects of the drug on the PD patients.  
A simple, logical way to test Klein's hypothesis is to compare reactions to breath holding in PD patients with other groups, because 
breath holding will cause arterial pCO2 to increase and stimulate the relevant physiological sensors. Three groups of researchers 
have used this approach. Zandbergen et al. [11] had patients with PD, patients with other anxiety disorders, and normal controls 
inhale a deep breath of 50% O2 and 50% N2 and then hold that breath as long as they could PD patients held their breath for a 
mean of 34 seconds, which was significantly different from normal controls (74 seconds), but not from patients with other anxiety 
disorders (49 seconds). The inhalation and breath holding procedure was repeated 3 minutes later after 1 minute of 
hyperventilation with the same results. Increase in self-reported anxiety with breath holding was small and not significantly 
different between the groups. Asmundson and Stein [12] had patients with PD, patients with generalized social phobia, and normal 
controls hold their breath three times after a normal exhalation for as long as possible. Patients with PD held their breath for a 
shorter time (mean = 16 seconds) than either comparison group (21 seconds for social phobics and 21 seconds for normal 
controls), but the groups did not differ in heart rate, respiratory sinus arrhythmia, respiratory frequency, or endtidal pCO2 before or 
after trials. Van der Does [13], had patients with PD, depressed patients, and normal controls hold their breath as long as they 
could, once after deep inhalation and three times after normal exhalation. As with Zanbergen et al. [11], PD patients held their 
breath shorter than controls after deep inhalation, but contrary to Asmundson and Stein [12], not after normal exhalation.  
Our experiment differed from the ones above in several ways. First, we used patients with GAD as a clinically anxious comparison 
group, because GAD patients have somatic anxiety symptoms similar to those of PD patients. Second, we had subjects complete a 
questionnaire that asked about past experiences with, and attitudes toward, shortness of breath. Third, we asked the subjects to 
hold their breaths for a signaled time period of 30 seconds. Specifying a moderate time that all subjects were expected to attain 
was an attempt to make uniform the physical aspect of the stressor to which we measured subjective and physiological responses 
and to reduce motivational effects, which cause considerable variation when people are told to hold their breath as long as they can 
[13-15]. Fourth, by asking subjects to repeat breath holding 12 times, we were better able to look for habituation or sensitization 
effects [16,17]. Fifth, more measurements were taken, including subjective emotional responses and a variety of cardiovascular, 
electrodermal, and respiratory variables.  
Our hypotheses were as follows: If the suffocation false alarm hypothesis is true, PD patients should report more fears related to 
breathing. They should have the largest psychological and physiological anxiety responses to breath holding, especially higher 
heart rate and skin conductance levels [18] during the breath holdings themselves. After individual breath holdings PD patients 
should show signs of greater respiratory drive and continued signs of greater autonomic activation, inasmuch as physiological 
anxiety reactions would be unlikely to vanish immediately upon temporary resumption of breathing, especially because breath 
holding will be soon repeated. However, if psychological causes predominate, we would expect fewer differences between groups, 
inasmuch as breath holding lacks some of the threat of other suffocation experiences: Subjects have a ready explanation for their 
sensations and know that they can turn them off at any time by resuming breathing. Control is known to attenuate the effects of 
anxiety provocations in PD patients [19], although reassuring explanations do not always block the effects of lactate [20] or CO (2) 




Nineteen patients with PD, 17 with GAD, and 22 normal controls were recruited by advertisement. Patients were candidates for 
clinical drug trials and were not paid for their participation, whereas controls were paid. Advertisements for controls asked for 
volunteers not suffering from excessive anxiety or stress. Diagnosis of patients and exclusion of anxiety disorders and other Axis I 
disorders in controls was made by the Structured Clinical Interview for DSM-III-R [22]. Eligible subjects signed a consent form 
before participation. Three of the GAD patients had a history of PD, but their PD was in full remission and they had no 
agoraphobia. Three of the PD patients currently met criteria for GAD in addition to PD. On the structured interview, PD patients 
had a mean (SD) panic attack severity of 1.9 (0.7) and agoraphobic avoidance severity of 2.3 (0.9) on scales where 4 is "severe" 
and 0 is "in full or partial remission." Three of the PD patients, two of the GAD patients, and one of the normal controls had a 
history of a major depressive episode, but none was having such an episode at the time of testing. All patients and normal controls 
denied taking psychoactive or cardiovascularly active medication in the 2 weeks before testing, although this was not verified by 
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drug screens. None of the subjects reported current respiratory disease. As noted in Table 1, groups were successfully selected not 
to differ significantly in age or in the proportion of women.  
 
 
Table 1. Description of Groups: Mean (SD)  
 
 
Before testing subjects filled out several questionnaires, including the Agoraphobic Cognitions Questionnaire [23], the Body 
Sensations Questionnaire [23], the Beck Depression Inventory [24], and the State-Trait Anxiety Inventory (STAI) Trait Form [25]. 
As can be seen in Table 1, the expected group differences were present. In addition, subjects filled out a Respiration Questionnaire, 
devised by the authors, comprising the 16 questions outlined in Table 2. For example, the first question was "How often have you 
had these experiences?" followed by a list of five items, the first of which was "1. Shortness of breath when anxious" followed by 
the numbers 1 to 4, above which were the anchors never/seldom/sometimes/often. Subjects were to circle the appropriate number.  
 
 
Table 2. Respiration Questionnaire: Mean (SD)  
 
 
Immediately before testing, PD patients reported on a questionnaire item having had a mean (SD) of 2.6 (2.1) panic attacks in the 
past 2 weeks; 14 of the 19 PD patients reported attacks in that period. Surprisingly, 3 of the 17 GAD patients reported panic 
attacks also: one reported five and two reported one. Note that subjects were not asked how many symptoms accompanied these 
attacks or other details to verify that the attacks met DSM criteria. The STAI-State Form was used in addition to our Mood 
Questionnaire (described below) to quantify state anxiety immediately before testing (20 items rated 1-4 allow a maximum score 
of 80) [25].  
Apparatustoctoc 
Eight physiological channels were recorded using the Vitaport I (Becker Engineering, Karlsruhe, Germany): 1) An 
electrocardiogram; 2) two channels of respiration from Respibands (Respitrace Corporation, Ardsley, NY) placed around the upper 
thorax centered on nipples and around the abdomen between the xiphoid process and the navel, and calibrated by having subjects 
breathe into a spirometer; 3) a continuous arterial blood pressure waveform from the index finger by means of the Finapres 2300 
(Omeda, Madison, WI) system; 4) skin conductance using a constant 0.5 V and isotonic electrode paste; 5) expiratory pCO2 
measured continuously by a calibrated infrared capnograph (Datex B, Puritan-Bennett Corporation, San Ramon, CA) into which 
air was drawn with a flow rate of 150 ml/minute through a 1.2-mm diameter plastic tube ending 2 to 4 mm inside the left nostril 
(subjects were instructed to breathe only through the nose); and 6) body movement sensed by accelerometers attached to the right 
thigh and shoulder.  
Proceduretoctoc 
Subjects sat upright in a comfortable chair during testing in a room held between 21 and 23[degree sign]C. Time of day was 
matched between the three groups. Subjects had had at least 45 minutes to adjust to their surroundings before the breath holding 
procedure began. It was introduced by written instructions: The subjects were informed that when they heard a single tone, they 
were first to quickly breathe out and then take a deep breath and hold it until they heard a double tone, which signaled that they 
were to resume breathing normally. All breathing was to be through the nose, not the mouth. The interval between single and 
double tones (the breath holding period) was 30 seconds, and the interval from a double tone to the next single tone (the normal 
breathing period) was 60 seconds. Twelve breath holding periods (trials) separated by 11 normal breathing periods occurred over 
18 minutes. In addition, the 30 seconds before the first breath holding and the 30 seconds after the last breath holding were 
included as normal breathing periods for purposes of data analysis. There was no mention in the instructions that anxiety or panic 
attacks might occur during the procedure nor provisions for its premature termination.  
Subjects rated their subjective emotional state immediately before and after (but not during) the breath holding procedure on our 
Mood Questionnaire, which consisted of four items: "anxious," "excited," "alert," and "in control." Using scales from 0 (not at all) 
to 10 (extremely strong) for each of the four items, subjects made ratings for four different time points. Before the procedure, they 
rated their current mood (this rating will be referred to subsequently as before). After the procedure they rated their current mood 
again (after) and, retrospectively, their average emotional state while breathing normally during the procedure (breathe) and their 
average while breath holding (hold).  
The last item on this questionnaire asked whether subjects had had "attacks during the test when you suddenly felt more 
frightened, anxious, or extremely uncomfortable," and how many such attacks they had had. If they answered yes, subjects were 
asked to fill out Symptom Questionnaire A for this episode (or the worst episode) so that we could determine whether it had 
resulted in four or more symptoms. Subjects for whom that was the case are referred to below as panickers. Symptom 
Questionnaire A was a list of the 13 symptoms comprising the diagnostic criteria for a panic attack in the Diagnostic and Statistical 
Manual of Mental Disorders, 3rd Edition-Revised (DSM-III-R) [26], after each one of which subjects circled "yes" or "no."  
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Finally, all subjects filled out Symptom Questionnaire B asking them "how you felt during any part of the last test." It listed the 13 
DSM-III-R symptoms with "heart racing, pounding, or skipping" combined with "chest pain or pressure" to give a total of 12 
items. Subjects rated each item on a 5-point scale from 0 = not at all to 4 = to a high degree.  
Data Analysistoctoc 
In off-line analyses, measurements derived from the channels were synchronized in time by the beginning of breath holdings for 
each subject and trial. The computer detected the onset of breath holding as a leveling off to zero of inspiratory change in the 
respiratory channels after a single signal tone. This allowed analysis to be divided into sets of three time periods: before (the last 
30 seconds of normal breathing), during (mean of 28 seconds from the end of inspiration to the beginning of expiration), and after 
each breath holding (the first 30 seconds of normal breathing). To avoid transition effects, only data from the first 20 seconds of 
the before period and the last 20 seconds of the after period were used.  
HR was analyzed with a program that computed estimates of instantaneous heart rate for every 0.5-second interval [27]. 
Respiratory sinus arrhythmia was calculated by spectral analysis [28]; 20-second epochs of heart rate data were linearly detrended, 
and then analyzed by the Fast Fourier transform using Welch's method. Respiratory sinus arrhythmia was estimated as the spectral 
power between 0.14 and 0.50 Hz. T-wave amplitude was determined by first locating the maximum value from 50 to 300 msec 
after an R wave. The difference between this maximum and the mean of the last 50 msec before the occurrence of the present R 
wave was taken as T wave amplitude [29]. Systolic and diastolic blood pressure were local maxima and minima in the continuous 
arterial blood pressure waveform. Movement channels were rectified, integrated, and added together. Skin conductance was 
analyzed as mean levels.  
The first step in analyzing the respiration channels was to convert the raw signals of the two bands to a calibrated instantaneous 
lung volume established by a spirometer calibration procedure conducted before the tests began [30]. We calculated a wide variety 
of respiratory parameters including respiratory rate, tidal volume, minute volume, inspiratory flow rate, inspiratory time, 
expiratory time, duty cycle (inspiratory time/total time), pause after inspiration, pause after expiration. Onset of inspiration, 
expiration, and pauses were defined by slope criteria (flow rates exceeding 100 ml/min defined onsets). Our analytic approach 
followed that introduced by Gautier [31], which assumes that respiration is under the control of a central "driving" mechanism 
turned on and off by a cyclic "timing" mechanism [32]. We estimate that after calibration the discrepancy between concurrent 
Respitrace and spirometric volume measures is within +/- 10%.  
End-tidal pCO2 was determined as the level at which pCO2 stopped rising at the end of an expiration (final maximum). Expirations 
with a low percentage of alveolar air can be recognized by the CO2 waveform not reaching a plateau [33], and these were 
excluded. We required plateaus to be present in 50% of breaths in a measuring epoch or it was discarded. For measurement of 
pCO2 in the first expiration after breath holding, the second expiration value was substituted in the few breath holdings in which it 
was greater. Presumably, in these cases the first expiration did not go completely through the nose. Such cases were not restricted 
to one group. Our statistical analysis for pCO2 was based on data for 11 PD patients, 14 GAD patients, and 14 normal controls. 
Besides failures to reach a plateau, in 3 PD patients and 2 normal controls the nasal tube did not remain in place, and in one PD 
patient and 3 normal controls data recording was faulty.  
Heart rates during breath holding were determined from ensemble averages synchronized with breath holding onsets and offsets. 
Offsets were set to +28 seconds (median breath holding time) from onsets, which resulted in the discarding of some data when 
breath holding was longer than 28 seconds, and the filling in of interpolated data when breath holding was shorter than 28 seconds. 
Trials in which breath holding was less than 20 seconds (1.8% of all trials) were discarded.  
Statistical analysis was generally repeated-measures ANOVA with probability levels adjusted by the Greenhouse-Geisser 
correction. Time effects during the procedure were examined after dividing the breath holdings into three consecutive sets of four 
trials, and taking the mean of each measure for each set. Using means helped to reduce error variance in the physiological 
measures. The Tukey-Kramer statistic was used for post hoc comparisons of means of the three diagnostic groups, and the 
unpaired t test for means of panickers and nonpanickers. Only main group effects and interactions with group are reported except 
for the analyses of the Mood Questionnaire. Certain demographic and questionnaire items needed to be analyzed with 
nonparametric tests. Our comparisons of patient panickers and patient nonpanickers included patients from both the PD and GAD 





During the test as defined above, 32% (6 of 19) of PD patients, 18% (3 of 17) of GAD patients, and 0% (0 of 22) of normal 
controls were panickers (chi squared (2) = 7.84, p < .02). The difference between PD and GAD patients was not significant (chi 
squared (1) = 0.93). None of the three GAD patients with a history of PD were panickers. Of the patients reporting attacks, the 





Results for the Respiration Questionnaire are presented in Table 2. PD patients endorsed higher scores than normal controls on 8 
of the 16 items and more than GAD patients on 3 items.  
 
Breath Holding Performancetoctoc 
Breath holding time was calculated from the end of initial inspiration following a single signal tone to the beginning of expiration 
following a double signal tone (or earlier, for subjects unable to hold their breath that long). The mean (SD) for PD was 26.5 (3.0) 
seconds, for GAD, 27.0 (2.1) seconds, and for normal controls 27.6 (1.7) seconds. ANOVA with time (three consecutive sets of 
four trials) as a repeated measure showed no main Group effect but a Group by Time interaction (F(4,102) = 4.03, p < .02), 
because for Trials 1 to 4 the PD patients held their breaths about 2 second shorter than other groups, whereas at the two other time 
points the mean times of the three groups differed less than 1 second. Although follow-up ANOVAs did not show significant 
diagnostic group differences, we analyzed the first four trials separately. There was no main Group effect, but again there was a 
Group by Time interaction (F(6,153) = 3.40, p < .01). Follow-up ANOVAs showed a Group difference for Trial 1 (F(2,51) = 4.50, 
p < .02), but not for any of the other three trials. Post hoc Tukey-Kramer tests showed that on Trial 1, PD patients differed (p < 
.05) from GAD patients and normal controls, but GAD patients and normal controls did not differ from each other. Mean breath 
holding time on Trial 1 was 23.6 seconds for PD, 27.3 seconds for GAD, and 27.5 seconds for normal controls.  
 
Mood Ratingstoctoc 
The diagnostic groups differed in mood ratings just before the procedure on the STAI-State Form (F(2,54) = 26.4, p < .0001). Post 
hoc Tukey-Kramer tests showed that PD and GAD patients both were higher (p < .05) than normal controls, but not different from 
each other. The mean for PD patients was 43.8, for GAD patients was 46.9, and for normal controls was 27.9. Figure 1 shows 
Mood Questionnaire scores for four time points: just before the procedure (before), average while breathing normally during the 
procedure (breathe), average while breath holding (hold), and just after the procedure (after). One set of ANOVAs compared 
pretest ratings, another pretest rating and posttest ratings (the first and last time points in the figure) and a third, breathe and hold 
data (the middle two time points in the figure). For before ratings Group effects were found only for "anxious" (F(2,55) = 11.7, p < 
.0001) and "excited" (F(2,55) = 3.40, p < .05). Post hoc tests showed that PD and GAD patients both rated themselves more 
anxious than normal controls but not different from each other. The statistics of the following two analyses appear in Table 3. For 
before/after (closely related to the previous analysis but capable of detecting changes over the test) both "anxious" and "excited" 
showed Group effects, but no before/after effects or interactions. For breathe/hold, "anxious" and "excited" showed the same 
Group effects as for before/after, but in addition a large breathe/hold effect due to increases from normal breathing to breath 




Figure 1. Means and standard errors of Mood Questionnaire scores for four time points: just before the breath holding procedure 
(before), average during the procedure while breathing normally (breathe), average during the procedure while breath holding 
(hold), and just after the procedure ended (after). Breathe and hold were rated retrospectively at that time. Groups are panic 





Table 3. ANOVAS for Mood Questionnaire Ratings: PD Patients, GAD Patients, and Normal Controls  
 
 
Panicking and nonpanicking patients did not differ significantly on the STAI-State Form, but differed in the Mood Questionnaire 
in that panickers were higher than nonpanickers on before ratings of "anxious" (t(34) = 2.68, p < .02) and "excited" (t(34) = 2.94, p 
< .006) but did not differ on "alert" or "in control." An absence of Group by before/after interactions (for "anxious," F(1,38) = 
0.51) means that panickers did not change more or less than nonpanickers. An absence of Group by breathe/hold interactions (for 
"anxious," F(1,38) = 2.51) means that panickers and nonpanickers did not rate their amount of change in mood during breath 
holding differently.  
 
Symptoms During the Breath Holding Proceduretoctoc 
The diagnostic groups differed on Symptom Questionnaire B in total scores (F(2,54) = 6.46, p < .005), number of symptoms 
(F(2,54) = 6.88, p < .005), and average severity of symptoms (F(2,54) = 5.77, p < .005). Post hoc Tukey-Kramer tests showed that 
for these three scores PD patients were significantly (p < .05) higher than normal controls and that GAD patients had intermediate 
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scores that were not significantly different from those of PD patients or normal controls. Individual symptoms that showed a group 
effect by the Kruskal-Wallis test with tie correction were "heart racing, pounding, skipping or chest pain or pressure," "dizziness, 
unsteadiness, or faintness," "unreality or detachment," "flushing," and "fear of going crazy," but not "shortness of breath."  
Panicking and nonpanicking patients also differed significantly on most items of Symptom Questionnaire B. Absolute means 
(SDs) for shortness of breath (on a five-point scale) were 2.78 (1.64) for panickers and 0.92 (1.16) for nonpanickers (p < .01 by the 
Mann-Whitney U test).  
 
Physiological Measures Before the First Breath Holdingtoctoc 
The 20-second period before the first breath holding is an indicator of baseline and anticipatory effects. None of the 
cardiovascular, electrodermal, or respiratory variables differed between the diagnostic groups at this time point. The F ratios for 
heart rate, systolic and diastolic blood pressure, skin conductance, and respiratory measures (including end-tidal pCO2) were less 
than 1.0. A comparison of the panicking and nonpanicking patients also failed to show differences. For end-tidal pCO2, t(21) 
equaled 0.03.  
The correlation between end-tidal pCO2 values before the first breath holding and the breath holding times for Trial 1 was 
significantly positive for all groups combined (r = 0.33, p < .03), but not for individual groups. Perhaps intolerance to feelings of 
suffocation arising from stress led to both initially lower pCO2 values and shorter breath holding times. These end-tidal pCO2 
values did not correlate with changes in anxiety between before and after or breathe and hold for the groups combined or any 
group.  
 
Physiological Measures During Breath Holdingstoctoc 
Cardiovascular measures responded to breath holding in a complex manner, illustrated for heart rate in Figure 2. Inspiration and 
onset of a breath holding is accompanied by cardiac acceleration (measured in individual subjects as the "inspiratory maximum" 
heart rate) followed by deceleration (measured as the "postinspiratory minimum") and a return to an intermediate HR level ("final 
breath holding" heart rate measured as the mean in a 10-second interval ending at the end of breath holding). The maximum may 
represent gating of cardiac vagal tone [34] whereas the minimum is a component of the "diving reflex" [35]. Expiration at the end 
of a breath holding is followed by a second acceleration ("post-breath holding maximum") due to the first inspiration after breath 
holding. This is followed by a "recovery" to intermediate levels. All of these measures were calculated as differences from 20-
second baselines ending 10 seconds before the onset of each breath holding. Only inspiratory maximum differed significantly 
(F(4,102) = 5.31, p < .005) between the three groups. Post hoc tests confirmed the statistical significance of the unexpected result 
that GAD patients had larger accelerations than PD patients or normal controls, with a tendency for this effect to become stronger 
in later trials. The changes in inspiratory time and tidal volume could not explain the difference in heart rate acceleration, 
inasmuch as they showed no Group effects or interactions. Skin conductance response amplitude to onset of breath holding 
showed no significant effects. None of the other cardiovascular variables, nor skin conductance level, nor bodily movement 
differed between groups or showed group interactions at any of the measurement points during breath holding.  
 
 
Figure 2. Averages of HR synchronized to onset and offset of breath holding over all 12 trials for the three diagnostic groups (see 
legend for Figure 1). Unlike in Figure 1, "before" and "after" refer to measurement points before and after individual trials, not 
before and after the entire procedure.  
 
 
pCO2 Before and Immediately After Each Breath Holdingtoctoc 
pCO2 for the first expiration after each breath holding and during the 20 seconds before each breath holding were averaged 
separately over three consecutive sets of four trials so that time effects could be evaluated. (Note that data from the time point 
before the first trial also appeared above in the analysis of measures before the first breath holding. Note also that in the following 
analyses, "before" and "after" refer to measurement points before and after individual breath holding trials, not before and after the 
entire procedure.) Figure 3 shows that of the three diagnostic groups, PD patients tended to have a lower pCO2 before and after, 
whereas the differences between before and after within each diagnostic group were approximately equal. A three-way ANOVA 
showed significant effects for Group (F(2,36) = 3.65, p < .04), Before-After (F(1,36) = 227.0, p < .0001), and Time (F(2,72) = 
23.1, p < .0001), but not for any of the interactions. Post hoc tests confirmed that pCO2 in PD was lower than in normal controls (p 
< .05), but in GAD was not significantly different from pCO2 in other groups. Times 1 and 2, and 1 and 3 differed significantly (p 
values < .0002), but not Times 2 and 3.  
 
 
Figure 3. Means and standard errors of end-tidal pCO2 before and at end of breath holdings for three consecutive sets of four trials 
for the three diagnostic groups (see legend for Figure 1). Unlike in Figure 1, "before breath holding" refers to measurements before 
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individual trials; correspondingly "at end of breath holding" refers to measurements after individual trials.  
 
 
Physiological Measures After Each Breath Holdingtoctoc 
The 20-second post-breath holding periods were grouped into three consecutive sets of four trials so that interactions of Time and 
Group effects could be evaluated. Among the respiratory measures, which included minute volume, tidal volume, and inspiratory 
flow rate, only pCO2 showed a main Group effect (F(2,36) = 3.81, p < .05). Post hoc tests showed again that pCO2 in PD was 
lower than in normal controls (p < .05), but in GAD was not significantly different from those in other groups. None of the 
respiratory measures showed a Group by Time interaction. Among measures of cardiovascular activation (heart rate, systolic and 
diastolic blood pressure, T wave amplitude, and respiratory sinus arrhythmia), electrodermal activation, and movement there were 
no main Group effects or Group by Time interactions.  
Exclusion of the Three GAD Patients With a Past History of PD. Because these patients may have had the psychophysiological 
characteristics of PD patients, additional analyses were made excluding them. On the Respiration Questionnaire, the same pattern 
of significance was present except for the item "Not getting enough air swimming." GAD patients had significantly higher scores 
than either PD patients or normal controls for both "How often" and "Ever severely frightened." The pattern of significance for the 
Mood Questionnaire was unaltered except that Group by Before/After for "in control" was no longer significant. The patterns of 
significance for heart rate change during breath holdings and for other physiological measures were not changed.  
DISCUSSIONtoctoc 
As stated in the introduction, if Klein's hypothesis is true, we would expect the largest psychological and physiological anxiety 
responses to breath holding in the PD patients, including higher heart rate and skin conductance responses during breath holdings 
and signs of greater respiratory drive and autonomic activation between them. After the first trial, our strategy of having subjects 
hold their breaths for 30 seconds was successful in producing a constant stimulus situation for all groups, but few of the expected 
results were observed. Contrary to the hypothesis, increases in self-reported anxiety from normal breathing to breath holding were 
the same for all diagnostic groups. Instead, group differences consisted of higher anxiety levels before the procedure in PD and 
GAD patients than in normal controls, with reactions to breath holding appearing as equal phasic increases added to unequal 
baselines, a pattern that has been observed in PD patients and normal controls with diverse provocations (eg, [36]). Tonically 
elevated anxiety baselines may explain why patients reported more panic attacks. Patients in general and panickers in particular 
began the procedure with more anxiety, making it easier for the additional anxiety of breath holding to push them above a 
threshold for answering the panic attack question affirmatively. In addition, because of fear of anxiety or bodily sensations, PD 
patients may have a nonspecifically lower threshold for reporting panic after stressors, which also would explain why they report 
panic attacks to such a wide variety of provocations (for a review, see [37]). Some of these explanations would need to extend to at 
least some of the GAD patients, which as a group did not differ statistically from the PD patients in the number of panic attacks 
reported during our procedure.  
The hypothesized greater physiological anxiety reactions in PD patients during and after individual breath holdings did not appear 
either. Because measuring a broad spectrum of potential physiological anxiety responses (HR, T wave amplitude, respiratory sinus 
arrhythmia, systolic and diastolic blood pressure, skin conductance level, and a wide variety of respiratory measures) made our 
testing procedure quite sensitive, the lack of any group differences goes strongly against Klein's hypothesis. However, in the case 
of HR measurements during breath holding, the "diving reflex" [35] may have altered our results somewhat. A component of this 
reflex is heart rate deceleration, which, if more intense in panicking patients than in nonpanickers, could have decreased rather 
than increased their heart rates during breath holding. Fear in some studies seemed to produce greater heart rate deceleration 
during breath holding [38]. However, these decelerative effects should be short-lived and not affect our final breath holding 
interval measurement, which also showed no HR differences. Finally, contrary to the suffocation alarm hypothesis, inspiratory 
flow rate in intervals after individual breath holdings, a measure of central respiratory drive [31], did not differ between groups.  
A curious, unexpected result was that an HR acceleration occurring just before breath holdings was greater for GAD patients than 
for other groups. This acceleration was probably the result of a combination of the physical effort expended for quick expiration 
and deep inspiration, and the transient decrease in intrathoracic pressure associated with inspiration, One might speculate that their 
worrying led GAD patients to prepare themselves more vigorously for breath holding than did other groups, but this was not 
supported by inspiratory time and tidal volume measurements. Because GAD and PD patients were well matched on state anxiety 
just before testing, differences between the patient groups can be more plausibly attributed to their type of anxiety than to its 
severity. However, it is possible that certain of our GAD patients had the specific biological characteristic of PD, if such a 
characteristic exists. Interview diagnosis is unlikely to distinguish perfectly between anxiety syndromes [39]. This may explain 
why GAD patients tended to fall between PD patients and normal controls on several measures and, in a few cases, reported panic 
attacks before or during the procedure.  
The pattern of results for one important physiological measure, end-tidal pCO2, is compatible with the suffocation false alarm 
hypothesis. The lower end-tidal pCO2 in PD patients compared with normal controls (although the difference between PD and 
GAD patients does not reach significance), could have been caused by hyperventilation in response to greater air hunger produced 
by an overly sensitive suffocation alarm. Because of the lower initial pCO2 levels in PD patients, breath holding increased pCO2 
only to normal, not to hypercapnic levels. This may have prevented psychological or physiological anxiety responses to breath 
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holdings from being greater in PD patients than in the other groups. In other words, an overly sensitive suffocation alarm could 
initially have produced increased respiratory drive, but as pCO2 decreased, this drive might have decreased to a normal level where 
phasic reactions to transient increases in pCO2 were also normal. Apparently, greater hyperventilation in PD patients seems to have 
been initially stimulated by breath holding, inasmuch as pCO2 did not differ between groups before the first trial. All groups 
showed small progressive decreases in pCO2 during the procedure, perhaps as a physiological adjustment to repeated breath 
holding or perhaps as a nonspecific stress reaction. Oddly, none of these pCO2 differences were reflected in significant differences 
in minute volume or inspiratory flow. Because pCO2 levels can change with minor imbalances between CO2 production and 
ventilation averaged over many minutes, we assume that the changes in ventilation were below the threshold of detection of our 
measurement methods.  
However, interpreting the lower end-tidal pCO2 in PD as a confirmation of the suffocation false alarm hypothesis is open to 
several objections. First, a more parsimonious interpretation of the lower pCO2 levels is that they are evidence for a 
hyperventilation theory of PD (eg, [40]). Observations of end-tidal pCO (2) and respiration over longer time periods might help 
clarify whether hyperventilation is primary or secondary in modulating the anxiety level of PD patients. Second, although absolute 
pCO2 levels after breath holding were lower in PD patients, possibly making the provocation weaker for them, relative changes are 
important for stimulating ventilation (see [41], p. 480). An average increase of 6 mm pCO2 is known to be a strong respiratory 
stimulus, more than doubling minute ventilation in normals even if pO2 is not allowed to decrease (eg, [42]). Thus, it is puzzling 
that the hypothesized hypersensitive suffocation alarm of PD patients failed to produce greater than normal psychological and 
physiological anxiety responses to individual breath holdings. Third, the hypocapnia that we observed may be a nonspecific 
reaction to stressors: pCO2 levels in PD may be more a reflection of the patients' fear rather than its cause. Lower pCO2 has been 
observed in normal subjects doing stressful desk work [43] and anxious non-PD patients engaged in fearful imagery [44]. 
Consistent with nonspecificity, it is observed following opposite respiratory stressors: breath holding and instructed 
hyperventilation [45]. On the other hand, one experiment suggests that hypocapnia is more characteristic of PD than GAD under 
mild challenge or baseline conditions even when self-reported anxiety is equal [46], which is similar to our results.  
Finally, it is important to note that not all possible versions of the suffocation false alarm hypothesis were tested by our breath 
holding experiment. First, if the fault in the biological monitor is intermittent, which could explain the infrequent and 
unpredictable occurrence of panic attacks in many PD patients, its malfunctioning might not be captured in an experimental run 
lasting only 18 minutes. More prolonged, probably ambulatory, measurements would be required. Second, if provocations 
producing uncomfortable levels of dyspnea in normal subjects are required to trigger the alarm in PD patients, our breath holding 
procedure was inadequate, because the levels of shortness of breath reported by most of our subjects, at least the ones not reporting 
panic, were low. On the other hand, these low levels of shortness of breath can be taken as evidence against the existence of a 
pathologically sensitive suffocation alarm. For a biological theory, the critical question is the adequacy of a change in pCO2 levels 
to stimulate a biological monitor. Purely psychological theories, such as those postulating catastrophic cognitive interpretations of 
interoceptions, are sufficient to account for group differences in response to provocations producing definite dyspneic discomfort 
in normal subjects. Our nonpanicking subjects may have failed to endorse the term shortness of breath very strongly because they 
did not consider it to apply to a voluntarily induced air hunger that was reliably alleviated by few deep breaths: Such air hunger is 
uncomfortable and likely to stimulate physiological monitors of suffocation, but is not necessarily frightening.  
The Respiration Questionnaire provided evidence both for and against the suffocation alarm hypothesis. For the hypothesis, PD 
patients experience shortness of breath when anxious more frequently and are more afraid of it than GAD patients or normal 
controls. PD patients also have had more experiences of past suffocation than the other two groups. On several other questions, PD 
patients answered in accordance with the suffocation alarm hypothesis compared with normal controls, although differences 
between PD patients and GAD patients did not reach significance. Against the hypothesis, PD patients were currently not more 
afraid of suffocation or choking than the other groups, and thought they could hold their breath as long. One explanation of this 
pattern of results is that after their first panic attacks, PD patients had learned to fear sensations for which they accepted the term 
"shortness of breath," but that they considered the words "suffocation" and "choking" as more specifically applicable to nonpanic 
situations such as being in a hot, humid place or having a piece of food caught in the trachea. Of course, retrospective self-report 
data are liable to various distortions that give them less weight than data obtained from direct physiological testing, especially 
when a physiocentric theory is being examined.  
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